ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,587.00
0.23%
S&P ASX All Technology
2,972.40
0.12%
Brent Oil
84.175
0.76%
US Dollar vs AUD
1.52807
-0.19%
Bitcoin
57,689.90
-0.94%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sunshine Biopharma Inc (SBFM)

  7. Sunshine Biopharma Inc (SBFM) News

SBFM

Sunshine Biopharma (SBFM)

Sunshine Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SBFM
DateTimeSourceHeadlineSymbolCompany
07/03/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
06/03/202408:37Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:SBFMSunshine Biopharma Inc
06/03/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
24/02/202408:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SBFMSunshine Biopharma Inc
22/02/202408:28Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SBFMSunshine Biopharma Inc
22/02/202400:24Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:SBFMSunshine Biopharma Inc
17/02/202409:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
16/02/202403:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
15/02/202407:53Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SBFMSunshine Biopharma Inc
15/02/202403:18Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SBFMSunshine Biopharma Inc
13/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SBFMSunshine Biopharma Inc
13/02/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
13/02/202401:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
10/02/202409:17Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SBFMSunshine Biopharma Inc
10/02/202400:59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
02/02/202408:17Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SBFMSunshine Biopharma Inc
31/01/202404:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
09/01/202400:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SBFMSunshine Biopharma Inc
08/12/202308:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
05/12/202300:30GlobeNewswire Inc.Sunshine Biopharma Moves Principal Office to New York CityNASDAQ:SBFMSunshine Biopharma Inc
14/11/202301:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
14/11/202300:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SBFMSunshine Biopharma Inc
03/11/202303:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
21/10/202304:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
20/10/202303:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SBFMSunshine Biopharma Inc
19/10/202304:32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
14/10/202301:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
06/09/202306:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
26/08/202305:16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
11/08/202323:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:SBFM

Your Recent History

FX
EURAUD
Euro vs AUD
ASX
CBA
Commonwealth Bank Of Aus...
NYSE
KO
Coca Cola
ASX
XMM
S&P ASX 300 Metals and M...
ASX
RIO
Rio Tinto
ASX
MQG
Macquarie
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
FX
GBPAUD
Sterling vs AUD
FX
AUDUSD
AUD vs US Dollar
NYSE
MCD
McDonalds
ASX
NAB
National Australia Bank
ASX
XFL
S&P ASX 50
ASX
WDC
Westfield
SPI
SP500
S&P 500
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved